Diabetes Drug's heart benefits probed in tiny study
NCT ID NCT05139914
First seen Feb 12, 2026 · Last updated May 11, 2026 · Updated 11 times
Summary
This study aimed to understand how dapagliflozin, a diabetes medication, might improve blood vessel health in people with type 2 diabetes. Researchers planned to measure changes in blood pressure and other vascular markers in a small group of participants. The study was terminated early and enrolled only 4 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BU School of Medicine Evans 748
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.